Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer

NCT02391480

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Breast Cancer, +47 more
Locations
  • Scottsdale Healthcare /ID# 132963 Scottsdale, Arizona, United States
  • City of Hope /ID# 154053 Duarte, California, United States
  • UC Davis Comp Cancer Ctr /ID# 154644 Sacramento, California, United States
  • Yale University /ID# 136982 New Haven, Connecticut, United States
View Trial Details
Completed

Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults

NCT02228772

Conditions
Acute Lymphoblastic Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, Hematologic Diseases, +12 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

NCT01197560

Conditions
Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • Providence St Joseph Medical Center/Cancer Center Burbank, California, United States
  • MD Anderson Cancer Center Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 57 locations
View Trial Details
Completed

A ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions

NCT03487432

Conditions
Calcified Coronary Artery Disease (Grade 3), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Universitäts-Herzzentrum Freiburg Bad Krozingen Bad Krozingen, Germany
  • Segeberger Kliniken GmbH Bad Segeberg, Germany
  • Herzzentrum Leipzig Leipzig, Germany
  • Deutsches Herzzentrum Muenchen München, Germany
View Trial Details
Completed

Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT

NCT01523834

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Azienda Ospedaliera SS. Antonio e Biagio e C. Arrigo Alessandria, Italy
  • Istituto di Ematologia ed Oncologia Medica A. Seragnoli Policlinico S. Orsola Bologna, Italy
  • Spedali Civili Brescia, Italy
  • Ematologia I, A.O.U. San Martino Genova, Italy
View Trial Details

Related conditions